Formulary restrictions and stroke risk in patients with atrial fibrillation
CONCLUSIONS: Limiting access to NOACs may exacerbate current underuse of anticoagulants and increase the risk of stroke among patients with newly diagnosed AF. Pharmacy benefit managers and Part D plans need to continuously review the appropriateness of formulary policies to ensure patient access to effective medications.PMID:36252171 | DOI:10.37765/ajmc.2022.89195
Source: The American Journal of Managed Care - Category: Health Management Authors: Bo Zhou Seth Seabury Dana Goldman Geoffrey Joyce Source Type: research
More News: Atrial Fibrillation | Health Management | Ischemic Stroke | Managed Care | Medicare | Stroke | Study | Vitamin K | Vitamins